Bluefin Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,237
| Closed | -$122K | – | 615 |
|
|
2021
Q4 | $122K | Sell |
15,237
-27,000
| -64% | -$216K | 0.01% | 476 |
|
|
2021
Q3 | $411K | Sell |
42,237
-11,000
| -21% | -$107K | 0.04% | 256 |
|
|
2021
Q2 | $527K | Buy |
53,237
+26,600
| +100% | +$263K | 0.03% | 217 |
|
|
2021
Q1 | $307K | Buy |
+26,637
| New | +$307K | 0.01% | 308 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 288 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 327 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 359 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 337 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 374 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 392 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 389 |
|
|
2017
Q1 | – | Sell |
-10,162
| Closed | -$368K | – | 386 |
|
|
2016
Q4 | $368K | Buy |
+10,162
| New | +$368K | 0.02% | 215 |
|
|
2016
Q1 | – | Sell |
-22,286
| Closed | -$1.46M | – | 429 |
|
|
2015
Q4 | $1.46M | Buy |
22,286
+1,381
| +7% | +$90.6K | 0.12% | 149 |
|
|
2015
Q3 | $1.18M | Sell |
20,905
-56,383
| -73% | -$3.18M | 0.07% | 159 |
|
|
2015
Q2 | $4.57M | Buy |
+77,288
| New | +$4.57M | 0.28% | 67 |
|
|
2015
Q1 | – | Sell |
-46,012
| Closed | -$2.65M | – | 436 |
|
|
2014
Q4 | $2.65M | Buy |
46,012
+18,412
| +67% | +$1.06M | 0.16% | 118 |
|
|
2014
Q3 | $1.48M | Buy |
+27,600
| New | +$1.48M | 0.08% | 193 |
|